US Stock MarketDetailed Quotes

ADAG Adagene

Watchlist
  • 2.550
  • -0.020-0.78%
Close May 17 16:00 ET
  • 2.820
  • +0.270+10.59%
Post 18:11 ET
112.50MMarket Cap-5821P/E (TTM)

About Adagene Company

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Company Profile

SymbolADAG
Company NameAdagene
Listing DateFeb 9, 2021
Issue Price19.00
Founded2011
CEODr. Peter Luo, PhD
MarketNASDAQ
Employees174
Securities TypeDR
ADS Ratio4.0 : 5.0
Fiscal Year Ends12-31
AddressSuzhou Industrial Park,No. 218 Xingh Street,4/F, Building C14
CitySuzhou
ProvinceJiangsu
CountryChina
Zip Code215123
Phone86-512-8777-3632
Websitehttp://www.adagene.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Peter Luo, PhD
  • President, R&D, Chairman of the Board and Chief Executive Officer
  • --
  • Dr. JC Xu, M.D.,PhD
  • Chief Scientific Officer
  • --
  • Dr. Qinghai Zhao, PhD
  • Chief Manufacturing Officer
  • --
  • Mr. Man Kin Tam
  • Director, Chief Financial Officer and Principal Accounting Officer
  • --
  • Mr. Alexander Goergen
  • Vice President and Head of Business Development
  • --
  • Ms. Xiaohong She
  • Senior Vice President and Head of Clinical Operations
  • --
  • Dr. Songmao Zheng, PhD
  • Vice President and Head of Clinical and Quantitative Pharmacology
  • --
  • Dr. Jiping Zha, M.D.
  • Executive Vice President, Clinical Development
  • --
  • Dr. Guizhong Liu, PhD
  • Senior Vice President, Early Drug Discovery
  • --
  • Ms. Yan Li, M.B.A.
  • Senior Vice President, Bioinformatics and Information Technology and Director
  • --
  • Dana Hu-Lowe
  • Vice President, Global Product Team Leadership
  • --
  • Ami C. Knoefler
  • Vice President, Investor Relations and Corporate Communications
  • --
  • Dr. Wenlin Zeng, PhD
  • Vice President, Early Stage CMC
  • --
  • Mr. Chunfang Gu
  • Senior Director of Finance
  • --
  • Ms. Yumeng Wang
  • Director
  • --
  • Ms. Ling Zhou
  • Executive Director of Human Resources
  • --
  • Cuong Viet Do
  • Independent Director
  • --
  • Dr. Ulf Grawunder, PhD
  • Independent Director
  • --
  • Dr. Mervyn Turner, PhD
  • Independent Director
  • --
  • Mr. Andy Cheung
  • Independent Director
  • --
  • Dr. Li Zhu, PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg